Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 3
Submit an article Journal homepage
56
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma

Arturo MontineriInfectious Diseases Unit, Ferrarotto Hospital, Catania, Italy
,
Luciano NigroCorrespondence[email protected]
,
Annalisa ChiarenzaHaematology Unit, University of Catania, Catania, Italy
,
Licia LaroccaInfectious Diseases Unit, Ferrarotto Hospital, Catania, Italy
,
Rosario La RosaInfectious Diseases Unit, Ferrarotto Hospital, Catania, Italy
,
Carmelo IacobelloInfectious Diseases Unit, Ferrarotto Hospital, Catania, Italy
,
Francesco Di RaimondoHaematology Unit, University of Catania, Catania, Italy
&
Filippo FatuzzoInfectious Diseases Unit, Ferrarotto Hospital, Catania, Italy
 show all
Pages 554-557 | Received 24 Aug 2009, Accepted 09 Dec 2009, Published online: 08 Feb 2010

References

  • Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107.
  • Mele A, Tosti ME, Spada E, et al Epidemiology of acute viral hepatitis: twenty years of surveillance through SEIEVA in Italy and a review of the literature. Rapporti ISTSAN 2006.
  • Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104–1108.
  • Marzano A, Angelucci E, Andreone P, et al Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 2007;39:397–408.
  • Takai S, Tsurumi H, Ando K, et al Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005;74:158–165.
  • Marcucci F, Mele A, Spada E, et al High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica 2006;91:554–557.
  • Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007;136:699–712.
  • Yeo W, Hui EP, Chan AT, et al Prevention of hepatitis B virus reactivation in patients with nasopharingeal carcinoma with lamivudine. Am J Clin Oncol 2005;28:379–384.
  • Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006;43:209–220.
  • Lok AS, Lai CL, Leung N, et al Long term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003;125:1714–1722.
  • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507–539.
  • Cabrerizo M, Bartolome J, Caramelo C. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000;32:116–123.
  • Maini MK, Bertoletti A. How can the cellular immune response control hepatitis B virus replication? J Vir Hepat 2000;7:321–326.
  • Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B reactivation during anticancer therapy. Hepatology 2006;43:209–220.
  • Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 2009;90:13–23.
  • Gish RG, Locarnini SA. Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol 2006;4:666–676.
  • Coco B, Olivieri F, Maina AM, et al Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360–369.
  • Liaw YF, Gane E, Leung N, et al 2-year globe trial results: telbivudine is superior to lamivudine in patients with chronichepatitis B. Gastroenterology 2009;136:486–495.
  • Keefee EB, Zeuzem S, Koff RS, et al Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroeterol Hepatol 2007;5:890–897.
  • European Association for the study of the Liver. EASL Clinical Practice Guideline: Management of chronic hepatitis B. J Hepatol 2009;50:227–242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.